Arrowhead Pharma
(ARWR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 44 | 44 | 159 | 44 | 48 |
| Gross Profit | 44 | 44 | 159 | 44 | 48 |
| Operating Expenses | 6,434 | 5,434 | 4,969 | 5,422 | 6,851 |
| Operating Income | -6,390 | -5,390 | -4,810 | -5,379 | -6,803 |
| Other Income | 212 | -1,549 | 29 | -222 | -1,437 |
| Pre-tax Income | -6,178 | -6,940 | -4,781 | -5,601 | -8,240 |
| Net Income Continuous | -6,178 | -6,940 | -4,781 | -5,601 | -8,240 |
| Net Income Discontinuous | N/A | 0 | 0 | 0 | 1 |
| Minority Interests | -99 | -182 | -167 | -287 | -248 |
| Net Income | $-6,079 | $-6,758 | $-4,614 | $-5,314 | $-7,992 |
| EPS Basic Total Ops | -0.23 | -0.41 | -0.33 | -0.44 | -0.71 |
| EPS Basic Continuous Ops | -0.24 | -0.42 | -0.33 | -0.44 | -0.71 |
| EPS Diluted Total Ops | -0.23 | -0.41 | -0.33 | -0.44 | -0.71 |
| EPS Diluted Continuous Ops | -0.24 | -0.42 | -0.33 | -0.44 | -0.71 |
| EBITDA(a) | $-5,890 | $-4,905 | $-4,360 | $-4,901 | $-6,406 |